Wird geladen...
How imiquimod licenses plasmacytoid dendritic cells to kill tumors
We have provided evidence for a multifaceted antitumor-function of the Toll-like receptor 7 (TLR7) agonist imiquimod, which rapidly recruits plasmacytoid dendritic cells and possibly other immune cells into tumors by inducing the secretion of CCL2 by dermal cells. Imiquimod induces pDC maturation an...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Landes Bioscience
2012
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3525638/ https://ncbi.nlm.nih.gov/pubmed/23264929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22033 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|